Diego O. Croci

5.9k total citations · 2 hit papers
63 papers, 4.6k citations indexed

About

Diego O. Croci is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Diego O. Croci has authored 63 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Immunology, 39 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Diego O. Croci's work include Galectins and Cancer Biology (49 papers), Glycosylation and Glycoproteins Research (28 papers) and Signaling Pathways in Disease (12 papers). Diego O. Croci is often cited by papers focused on Galectins and Cancer Biology (49 papers), Glycosylation and Glycoproteins Research (28 papers) and Signaling Pathways in Disease (12 papers). Diego O. Croci collaborates with scholars based in Argentina, United States and France. Diego O. Croci's co-authors include Gabriel A. Rabinovich, Marta A. Toscano, Mariana Salatino, Juan M. Ilarregui, Germán A. Bianco, Juan P. Cerliani, Norberto W. Zwirner, Santiago P. Méndez‐Huergo, Karina V. Mariño and Françoise Poirier and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Diego O. Croci

62 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death

2007 521 citations Marta A. Toscano, Germán A. Bianco et al. profile →
Targeting galectin-driven regulatory circuits in cancer and fibrosis

2023 135 citations Karina V. Mariño, Alejandro J. Cagnoni et al. profile →

Peers

Diego O. Croci

IMMUN

ONCOL

SURGE

Holger Karsunky United States

William G. Kerr United States

Robert A. Mitchell United States

Hui‐Chen Hsu United States

Yves Lepelletier France

Ute Koch Switzerland

Jack D. Bui United States

Camilla Jandus Switzerland

Makio Iwashima United States

Darren P. Baker United States

Holger Karsunky United States

Diego O. Croci

2.8k ×0.8

IMMUN

2.4k ×0.9

1.0k ×1.2

ONCOL

340 ×1.3

147 ×0.7

SURGE

Citations per year, relative to Diego O. Croci Diego O. Croci (= 1×) peers Holger Karsunky

Countries citing papers authored by Diego O. Croci

Since Specialization

Citations

This map shows the geographic impact of Diego O. Croci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego O. Croci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego O. Croci more than expected).

Fields of papers citing papers by Diego O. Croci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego O. Croci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego O. Croci. The network helps show where Diego O. Croci may publish in the future.

Co-authorship network of co-authors of Diego O. Croci

This figure shows the co-authorship network connecting the top 25 collaborators of Diego O. Croci. A scholar is included among the top collaborators of Diego O. Croci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego O. Croci. Diego O. Croci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carón, Rubén W., et al.. (2025). Proangiogenic effects of peritumoral adipose tissue in kidney cancer. Frontiers in Medicine. 12. 1652589–1652589.

Croci, Diego O., et al.. (2023). Extracellular vesicles from human plasma dampen inflammation and promote tissue repair functions in macrophages. Journal of Extracellular Vesicles. 12(6). e12331–e12331. 36 indexed citations

Croci, Diego O., et al.. (2022). Galectins as potential therapeutic targets in STIs in the female genital tract. Nature Reviews Urology. 19(4). 240–252. 11 indexed citations

Vliet, Sandra J. van, Paula Carasi, Pablo Andrés García, et al.. (2021). The Tn antigen promotes lung tumor growth by fostering immunosuppression and angiogenesis via interaction with Macrophage Galactose-type lectin 2 (MGL2). Cancer Letters. 518. 72–81. 34 indexed citations

Morosi, Luciano Gastón, Alejandro J. Cagnoni, Diego O. Croci, et al.. (2021). Control of intestinal inflammation by glycosylation-dependent lectin-driven immunoregulatory circuits. Science Advances. 7(25). 16 indexed citations

Cagnoni, Alejandro J., Ada G. Blidner, Rosa María Morales, et al.. (2021). Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8 ⁺ regulatory T cells. Proceedings of the National Academy of Sciences. 118(21). 86 indexed citations

Torres, Nicolás I., et al.. (2021). Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma. International Journal of Molecular Sciences. 23(1). 316–316. 17 indexed citations

Wolosiuk, Alejandro, et al.. (2016). Glyco-nano-oncology: Novel therapeutic opportunities by combining small and sweet. Pharmacological Research. 109. 45–54. 33 indexed citations

Croci, Diego O. & Gabriel A. Rabinovich. (2014). Linking tumor hypoxia with VEGFR2 signaling and compensatory angiogenesis. OncoImmunology. 3(6). e29380–e29380. 16 indexed citations

10.

Croci, Diego O., et al.. (2014). Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment. Glycobiology. 24(12). 1283–1290. 51 indexed citations

11.

Cerliani, Juan P., Tomás Dalotto‐Moreno, Daniel Compagno, et al.. (2014). Study of Galectins in Tumor Immunity: Strategies and Methods. Methods in molecular biology. 1207. 249–268. 6 indexed citations

12.

Croci, Diego O., Juan P. Cerliani, Tomás Dalotto‐Moreno, et al.. (2014). Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors. Cell. 156(4). 744–758. 414 indexed citations

13.

Salatino, Mariana, Diego O. Croci, Diego J. Laderach, et al.. (2014). Regulation of Galectins by Hypoxia and Their Relevance in Angiogenesis: Strategies and Methods. Methods in molecular biology. 1207. 293–304. 3 indexed citations

14.

Etulain, Julia, Soledad Negrotto, María Virginia Tribulatti, et al.. (2014). Control of Angiogenesis by Galectins Involves the Release of Platelet-Derived Proangiogenic Factors. PLoS ONE. 9(4). e96402–e96402. 48 indexed citations

15.

Laderach, Diego J., Lucas D. Gentilini, Diego O. Croci, et al.. (2012). A Unique Galectin Signature in Human Prostate Cancer Progression Suggests Galectin-1 as a Key Target for Treatment of Advanced Disease. Cancer Research. 73(1). 86–96. 138 indexed citations

16.

Croci, Diego O. & Mariana Salatino. (2011). Tumor Immune Escape Mechanisms that Operate During Metastasis. Current Pharmaceutical Biotechnology. 12(11). 1923–1936. 20 indexed citations

17.

Cooper, Dianne, Juan M. Ilarregui, Susana Pesoa, et al.. (2010). Multiple Functional Targets of the Immunoregulatory Activity of Galectin-1. Methods in enzymology on CD-ROM/Methods in enzymology. 480. 199–244. 35 indexed citations

18.

Zwirner, Norberto W., Diego O. Croci, Carolina I. Domaica, & Gabriel A. Rabinovich. (2009). Overcoming the Hurdles of Tumor Immunity by Targeting Regulatory Pathways in Innate and Adaptive Immune Cells. Current Pharmaceutical Design. 16(3). 255–267. 20 indexed citations

19.

Salatino, Mariana, Diego O. Croci, Germán A. Bianco, et al.. (2007). Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer. Expert Opinion on Biological Therapy. 8(1). 45–57. 74 indexed citations

20.

Toscano, Marta A., Juan M. Ilarregui, Germán A. Bianco, et al.. (2007). Dissecting the pathophysiologic role of endogenous lectins: Glycan-binding proteins with cytokine-like activity?. Cytokine & Growth Factor Reviews. 18(1-2). 57–71. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact